(Q38081692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Signalling bias in new drug discovery: detection, quantification and therapeutic impact (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Terry Kenakin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

15 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

205-216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrd3954

23 February 2020

exact match

0 references

cites work

Agonist-receptor efficacy. II. Agonist trafficking of receptor signals

1 reference

Functional selectivity and biased receptor signaling.

31 March 2020

1 reference

Multiple signaling states of G-protein-coupled receptors

31 March 2020

1 reference

Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery

31 March 2020

1 reference

Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors

31 March 2020

1 reference

Morphine side effects in beta-arrestin 2 knockout mice

31 March 2020

1 reference

Enhanced morphine analgesia in mice lacking beta-arrestin 2

31 March 2020

2 references

31 March 2020

12 December 2020

A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.

1 reference

An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization

31 March 2020

1 reference

Multiple mechanisms of serotonergic signal transduction

31 March 2020

1 reference

Differential signal transduction by five splice variants of the PACAP receptor

31 March 2020

1 reference

Selective signaling via unique M1 muscarinic agonists

31 March 2020

1 reference

Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands

31 March 2020

1 reference

Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus

31 March 2020

1 reference

Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction.

31 March 2020

1 reference

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist toward neuropeptide and chemokine receptors

31 March 2020

1 reference

Biased inhibition by a suramin analogue of A1-adenosine receptor/G protein coupling in fused receptor/G protein tandems: the A1-adenosine receptor is predominantly coupled to Goalpha in human brain.

31 March 2020

1 reference

Measures of efficacy using G proteins as endpoints: differential engagement of G proteins through single receptors

31 March 2020

1 reference

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

31 March 2020

1 reference

Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs

31 March 2020

1 reference

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

31 March 2020

1 reference

Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias

31 March 2020

1 reference

Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy

31 March 2020

1 reference

Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes

31 March 2020

1 reference

Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor

31 March 2020

1 reference

Use of fluorescence spectroscopy to study conformational changes in the beta 2-adrenoceptor

31 March 2020

1 reference

Molecular basis of inverse agonism in a G protein-coupled receptor

31 March 2020

1 reference

Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists

31 March 2020

1 reference

Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies

31 March 2020

1 reference

Kinetics of G-protein-coupled receptor signals in intact cells

31 March 2020

1 reference

Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes.

31 March 2020

1 reference

Plasmon-waveguide resonance (PWR) spectroscopy for directly viewing rates of GPCR/G-protein interactions and quantifying affinities

31 March 2020

1 reference

Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling

31 March 2020

1 reference

Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor.

31 March 2020

1 reference

Molecular characterization of a purified 5-HT4 receptor: a structural basis for drug efficacy

31 March 2020

1 reference

Crystal structure of rhodopsin: implications for vision and beyond

31 March 2020

1 reference

Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors

31 March 2020

1 reference

Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.

31 March 2020

1 reference

A simple method for quantifying functional selectivity and agonist bias

31 March 2020

1 reference

Imprecision in presentation of binding studies

31 March 2020

1 reference

Validity of the operational model

31 March 2020

1 reference

Genetic deletion of p90 ribosomal S6 kinase 2 alters patterns of 5-hydroxytryptamine 2A serotonin receptor functional selectivity

31 March 2020

1 reference

μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization

31 March 2020

1 reference

Analysis of multiple histamine H₄ receptor compound classes uncovers Gαi protein- and β-arrestin2-biased ligands

31 March 2020

1 reference

Where have all the active receptor states gone?

31 March 2020

1 reference

Crystal structure of the β2 adrenergic receptor-Gs protein complex

31 March 2020

1 reference

Structure of a nanobody-stabilized active state of the β(2) adrenoceptor

31 March 2020

1 reference

Analysis of allosterism in functional assays

31 March 2020

1 reference

Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors

31 March 2020

1 reference

Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes

31 March 2020

1 reference

An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation

31 March 2020

1 reference

On the analysis of ligand-directed signaling at G protein-coupled receptors

31 March 2020

1 reference

Quantifying ligand bias at seven-transmembrane receptors.

31 March 2020

1 reference

Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists.

31 March 2020

1 reference

Modeling of bias for the analysis of receptor signaling in biochemical systems

31 March 2020

1 reference

Islet amyloid polypeptide stimulates cyclic AMP accumulation via the porcine calcitonin receptor

31 March 2020

1 reference

The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists.

31 March 2020

1 reference

Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs.

31 March 2020

1 reference

Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.

31 March 2020

1 reference

Expression of V1A and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition.

31 March 2020

1 reference

Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells

31 March 2020

1 reference

Biased signalling and allosteric machines: new vistas and challenges for drug discovery

31 March 2020

1 reference

G protein-coupled receptor allosterism and complexing

31 March 2020

1 reference

Allosteric binding sites on cell-surface receptors: novel targets for drug discovery

31 March 2020

1 reference

Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.

31 March 2020

1 reference

Allosteric Modulation of G Protein–Coupled Receptors

31 March 2020

1 reference

New concepts in drug discovery: collateral efficacy and permissive antagonism

31 March 2020

1 reference

Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.

31 March 2020

1 reference

Dual signaling is differentially activated by different active states of the metabotropic glutamate receptor 1alpha

31 March 2020

1 reference

Identification of allosteric peptide agonists of CXCR4.

31 March 2020

1 reference

Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptor.

31 March 2020

1 reference

Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes

31 March 2020

1 reference

A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties

31 March 2020

1 reference

Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity

31 March 2020

1 reference

Prediction of functionally selective allosteric interactions at an M3 muscarinic acetylcholine receptor mutant using Saccharomyces cerevisiae

31 March 2020

1 reference

A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathway

31 March 2020

1 reference

Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor.

31 March 2020

1 reference

Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening.

31 March 2020

1 reference

Allosteric modulation of endogenous metabolites as an avenue for drug discovery.

31 March 2020

1 reference

Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes

31 March 2020

1 reference

Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.

31 March 2020

1 reference

Molecular determinants of angiotensin II type 1 receptor functional selectivity

31 March 2020

1 reference

Beta-arrestin-biased ligands at seven-transmembrane receptors

31 March 2020

1 reference

Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

31 March 2020

1 reference

Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.

31 March 2020

1 reference

Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure

31 March 2020

1 reference

TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure

31 March 2020

1 reference

Subtype specific roles of beta-adrenergic receptors in apoptosis of adult rat ventricular myocytes

31 March 2020

1 reference

Beta-blockers in heart failure: are pharmacological differences clinically important?

31 March 2020

1 reference

A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling

31 March 2020

1 reference

beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice

31 March 2020

1 reference

Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer

31 March 2020

1 reference

The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo.

31 March 2020

1 reference

H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway

31 March 2020

1 reference

GPCR functional selectivity has therapeutic impact

31 March 2020

1 reference

31 March 2020

1 reference

Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways.

31 March 2020

1 reference

A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation.

31 March 2020

1 reference

Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2

31 March 2020

1 reference

Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors

31 March 2020

1 reference

Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse

31 March 2020

1 reference

Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo

31 March 2020

1 reference

Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo

31 March 2020

1 reference

Meningococcus Hijacks a β2-adrenoceptor/β-Arrestin pathway to cross brain microvasculature endothelium

31 March 2020

1 reference

Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects

31 March 2020

1 reference

Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells

31 March 2020

1 reference

12 December 2020

The Thyrotropin Receptor and the Regulation of Thyrocyte Function and Growth*

1 reference

12 December 2020

The relative efficiency of beta adrenoceptor coupling to myocardial inotropy and diastolic relaxation: organ-selective treatment for diastolic dysfunction

1 reference

12 December 2020

Nicotinic acid receptor agonists differentially activate downstream effectors

1 reference

12 December 2020

Operational models of pharmacological agonism.

1 reference

12 December 2020

On the measurement of the affinity of partial agonists for receptors

1 reference

12 December 2020

Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2.

1 reference

12 December 2020

AN ATTEMPT TO STUDY THE EFFECTS OF CHEMICAL STRUCTURE ON THE AFFINITY AND EFFICACY OF COMPOUNDS RELATED TO ACETYLCHOLINE.

1 reference

12 December 2020

A modification of receptor theory

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRD3954

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23411724%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference